USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL

OBJECTIVE: To compare the efficacy of combination of ketamine plus midazolam with that of ketamine alone in the prevention of shivering during spinal anaesthesia METHODOLOGY: This double blinded randomized controlled clinical trial was carried out at institute of kidney diseases Hayatabad, Pesha­wa...

Full description

Bibliographic Details
Main Author: Mohammad Abbas Tariq Abbasi
Format: Article
Language:English
Published: Khyber Medical University 2014-03-01
Series:Khyber Medical University Journal
Online Access:https://www.kmuj.kmu.edu.pk/article/view/11771
id doaj-8ba23baf48024bfaa30ee0f699b208f2
record_format Article
spelling doaj-8ba23baf48024bfaa30ee0f699b208f22020-11-25T01:00:12ZengKhyber Medical UniversityKhyber Medical University Journal2305-26432305-26512014-03-01615811771USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIALMohammad Abbas Tariq Abbasi0Department of Anaesthesia Institute of Kidney Diseases Hayatabad Medical Complex PeshawarOBJECTIVE: To compare the efficacy of combination of ketamine plus midazolam with that of ketamine alone in the prevention of shivering during spinal anaesthesia METHODOLOGY: This double blinded randomized controlled clinical trial was carried out at institute of kidney diseases Hayatabad, Pesha­war from 16 October 2012 to 15 April 2013. Two hundred patients, classified by American Society of Anesthesiologists (ASA) physical status category I-II, listed for urologic surgery were randomized by card method in two groups of 100 patients each. Subarachnoid (spinal) anaesthesia was performed in all patients with bupivacaine 15 mg. The patients were randomly allocated to receive ketamine 0.25 mg/kg plus midazolam 37.5 μg/kg (Group A) or ketamine 0.5 mg/kg (Group B). During surgery, a shivering score was recorded at 5 min intervals. If 15 minutes after spinal anaesthesia and concomitant administration of a prophylactic dose of one of the study drugs, grade 3 or 4 shivering was noted, the prophylaxis was regarded as ineffective and pethidine 25 mg intravenously was administered. RESULTS: After 15 min, the incidences of shivering in groups A and B were 4% and 25% (P= <0.0001). Mean shivering score was 0.05±0.26112 and 0.43±0.87911 in group A and group B respectively. The number of patients with a shivering score of ≥3 was significant­ly higher in group B compared with groups A (4 vs. 0, respectively, P=0.0434). CONCLUSION: Prophylactic use of ketamine (0.25 mg/kg) plus mid­azolam (37.5 μg/kg) intravenously was more effective than ketamine (0.5 mg/kg) intravenous alone in preventing shivering developed during spinal anaesthesia.https://www.kmuj.kmu.edu.pk/article/view/11771
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad Abbas Tariq Abbasi
spellingShingle Mohammad Abbas Tariq Abbasi
USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
Khyber Medical University Journal
author_facet Mohammad Abbas Tariq Abbasi
author_sort Mohammad Abbas Tariq Abbasi
title USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
title_short USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
title_full USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
title_fullStr USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
title_full_unstemmed USE OF KETAMINE PLUS MIDAZOLAM VERSUS KETAMINE ALONE IN PREVENTION OF SHIVERING DURING SPINAL ANAESTHESIA: A RANDOMIZED CONTROLLED TRIAL
title_sort use of ketamine plus midazolam versus ketamine alone in prevention of shivering during spinal anaesthesia: a randomized controlled trial
publisher Khyber Medical University
series Khyber Medical University Journal
issn 2305-2643
2305-2651
publishDate 2014-03-01
description OBJECTIVE: To compare the efficacy of combination of ketamine plus midazolam with that of ketamine alone in the prevention of shivering during spinal anaesthesia METHODOLOGY: This double blinded randomized controlled clinical trial was carried out at institute of kidney diseases Hayatabad, Pesha­war from 16 October 2012 to 15 April 2013. Two hundred patients, classified by American Society of Anesthesiologists (ASA) physical status category I-II, listed for urologic surgery were randomized by card method in two groups of 100 patients each. Subarachnoid (spinal) anaesthesia was performed in all patients with bupivacaine 15 mg. The patients were randomly allocated to receive ketamine 0.25 mg/kg plus midazolam 37.5 μg/kg (Group A) or ketamine 0.5 mg/kg (Group B). During surgery, a shivering score was recorded at 5 min intervals. If 15 minutes after spinal anaesthesia and concomitant administration of a prophylactic dose of one of the study drugs, grade 3 or 4 shivering was noted, the prophylaxis was regarded as ineffective and pethidine 25 mg intravenously was administered. RESULTS: After 15 min, the incidences of shivering in groups A and B were 4% and 25% (P= <0.0001). Mean shivering score was 0.05±0.26112 and 0.43±0.87911 in group A and group B respectively. The number of patients with a shivering score of ≥3 was significant­ly higher in group B compared with groups A (4 vs. 0, respectively, P=0.0434). CONCLUSION: Prophylactic use of ketamine (0.25 mg/kg) plus mid­azolam (37.5 μg/kg) intravenously was more effective than ketamine (0.5 mg/kg) intravenous alone in preventing shivering developed during spinal anaesthesia.
url https://www.kmuj.kmu.edu.pk/article/view/11771
work_keys_str_mv AT mohammadabbastariqabbasi useofketamineplusmidazolamversusketaminealoneinpreventionofshiveringduringspinalanaesthesiaarandomizedcontrolledtrial
_version_ 1725214583904272384